A decade in to Andy Plump’s overhaul of Takeda’s R&D strategy, the plan is still evolving. Before Plump joined Takeda, the company was a small-molecule-focused organization. Plump and his colleagues ...
Bionic Biologics represent a novel therapeutic modality that integrates principles of biologic and synthetic design. This innovative platform enables the targeting of well-validated yet previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results